Llovet JM - Search Results

1

Molecular targeted therapies in hepatocellular carcinoma: from pre-clinical models to clinical trials.

Newell P, Villanueva A, Llovet JM. Newell P, et al. Among authors: llovet jm. J Hepatol. 2008 Jul;49(1):1-5. doi: 10.1016/j.jhep.2008.04.006. Epub 2008 Apr 28. J Hepatol. 2008. PMID: 18486262 Free article. No abstract available.

2

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.

Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodés J; EASL Panel of Experts on HCC. Bruix J, et al. Among authors: llovet jm. J Hepatol. 2001 Sep;35(3):421-30. doi: 10.1016/s0168-8278(01)00130-1. J Hepatol. 2001. PMID: 11592607 No abstract available.

3

Gene expression profiles in hepatocellular carcinoma: not yet there.

Llovet JM, Wurmbach E. Llovet JM, et al. J Hepatol. 2004 Aug;41(2):336-9. doi: 10.1016/j.jhep.2004.06.002. J Hepatol. 2004. PMID: 15288485 Review. No abstract available.

4

Non-surgical therapies of hepatocellular carcinoma.

Llovet JM, Sala M. Llovet JM, et al. Eur J Gastroenterol Hepatol. 2005 May;17(5):505-13. doi: 10.1097/00042737-200505000-00006. Eur J Gastroenterol Hepatol. 2005. PMID: 15827440 Review.

5

Percutaneous ethanol injection for hepatocellular carcinoma: alive or dead?

Lencioni R, Llovet JM. Lencioni R, et al. Among authors: llovet jm. J Hepatol. 2005 Sep;43(3):377-80. doi: 10.1016/j.jhep.2005.06.001. J Hepatol. 2005. PMID: 16005537 No abstract available.

6

How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated?

Schwartz M, Roayaie S, Llovet J. Schwartz M, et al. J Hepatol. 2005 Oct;43(4):584-9. doi: 10.1016/j.jhep.2005.07.019. J Hepatol. 2005. PMID: 16120468 Review. No abstract available.

7

Risk factors for hepatocellular carcinoma in HCV-cirrhosis: what we know and what is missing.

Fattovich G, Llovet JM. Fattovich G, et al. Among authors: llovet jm. J Hepatol. 2006 Jun;44(6):1013-6. doi: 10.1016/j.jhep.2006.04.001. J Hepatol. 2006. PMID: 16678654 No abstract available.

8

Systematic review: evidence-based management of hepatocellular carcinoma--an updated analysis of randomized controlled trials.

Lopez PM, Villanueva A, Llovet JM. Lopez PM, et al. Among authors: llovet jm. Aliment Pharmacol Ther. 2006 Jun 1;23(11):1535-47. doi: 10.1111/j.1365-2036.2006.02932.x. Aliment Pharmacol Ther. 2006. PMID: 16696801 Free article. Review.

9

A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.

Llovet JM, Chen Y, Wurmbach E, Roayaie S, Fiel MI, Schwartz M, Thung SN, Khitrov G, Zhang W, Villanueva A, Battiston C, Mazzaferro V, Bruix J, Waxman S, Friedman SL. Llovet JM, et al. Gastroenterology. 2006 Dec;131(6):1758-67. doi: 10.1053/j.gastro.2006.09.014. Epub 2006 Sep 19. Gastroenterology. 2006. PMID: 17087938

10

Neoadjuvant therapies for hepatocellular carcinoma before liver transplantation: a critical appraisal.

Lopez PM, Villanueva A, Roayaie S, Llovet JM. Lopez PM, et al. Among authors: llovet jm. Liver Transpl. 2006 Dec;12(12):1747-54. doi: 10.1002/lt.21018. Liver Transpl. 2006. PMID: 17133591 Free article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

361 results

Search Page

Filters